{
  "schema_version": "blend_json_v1",
  "blend": {
    "slug": "cagri-sema",
    "display_name": "Cagrilintide / Semaglutide",
    "status": "parked",
    "taxonomy_keys": [
      "metabolic_weight_blend"
    ],
    "components": [
      "cagrilintide",
      "semaglutide"
    ],
    "components_unresolved": [],
    "sections": {
      "overview": [
        {
          "text": "Pep-Talk curation pending: we’re reviewing the evidence and will expand this section soon.",
          "evidence_refs": [
            "E1"
          ]
        }
      ],
      "claims": [],
      "safety": [
        {
          "text": "Pep-Talk curation pending: we’re reviewing the evidence and will expand this section soon.",
          "evidence_refs": []
        }
      ]
    },
    "evidence": [
      {
        "id": "E1",
        "title": "Cagrilintide / Semaglutide — reference index",
        "source_type": "website",
        "source_id": "https://pubmed.ncbi.nlm.nih.gov/?term=Cagrilintide+/+Semaglutide",
        "evidence_grade": "mechanistic_only",
        "notes": "Index link for literature discovery. This file intentionally contains no protocol instructions."
      }
    ],
    "disclaimer": {
      "text": "This blend page is informational. It does not provide protocols or instructions. Claims must be supported by cited evidence.",
      "updated_at": "2026-01-19"
    },
    "meta": {
      "generated_from": "content/blends/_index.json",
      "generated_at": "2026-01-19"
    },
    "practical": {
      "bottom_line": "Pep-Talk curation pending: this practical summary will be expanded with real-world uses, common downsides, and red flags as evidence is reviewed.",
      "benefits": [],
      "common_downsides": [],
      "serious_red_flags": [],
      "who_should_be_cautious": [],
      "schema_version": "blend_practical_block_v1"
    }
  }
}
